Skip to main content

Regencell Bioscience Holdings Ltd

RGC
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0001829667

No open-market purchases or sales by Regencell Bioscience Holdings Ltd insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $8.56M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Regencell Bioscience Holdings Ltd changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of RGC: Q1 2026 compared with Q2 2026
MeasureQ1 2026Q2 2026Change
Holders3135+4
Shares647.2K1.40M+757.7K (+117.1%)
Value$16.5M$8.56M−$7.90M (−48.0%)

New holders (16)

Institutions that held Regencell Bioscience Holdings Ltd at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to RGC in Q2 2026
InstitutionSharesValue% of portfolio
Alyeska Investment Group, L.P.416,261$2.54M0.01%
Jane Street Group, LLC98,348$598.9K0.00%
XTX Topco Ltd60,061$365.8K0.00%
Quadrature Capital Ltd41,750$254.3K0.00%
Susquehanna International Group, LLP23,129$140.9K0.00%
Fox Run Management, L.L.C.20,691$126.0K0.02%
CIBC Asset Management Inc15,292$93.1K0.00%
Two Sigma Investments, LP14,406$87.7K0.00%
State of Wyoming4,070$24.8K0.00%
Aquatic Capital Management LLC2,058$12.5K0.00%
Simplex Trading, LLC1,717$10.5K0.00%
Larson Financial Group LLC168$1.02K0.00%
Jones Financial Companies LLLP99$6420.00%
Ameritas Advisory Services, LLC19$1160.00%
BNP Paribas Arbitrage, SA3$180.00%
Silver Grove Financial Group, Inc.1$60.00%

Sold out (12)

Institutions that held Regencell Bioscience Holdings Ltd at the end of Q1 2026 and filed for Q2 2026 without it.